Scarica l'app Stockscreener
0.00
100.00%
-3.37
Acasti Pharma Inc Azioni (ACST) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Research and Development |
213.70%
1.443
|
0.46 | 1.095 | 1.64 | 2.45 |
| Operating Income/Loss |
45.46%
-3.043
|
-2.092 | -4.454 | -38.07 | -4.245 |
| Nonoperating Income/Loss |
127.29%
0.444
|
-1.627 | 0.142 | 0.115 | 0.082 |
| Income/Loss From Continuing Operations Before Tax |
30.12%
-2.599
|
-3.719 | -4.312 | -37.96 | -4.163 |
| Income Tax Expense/Benefit |
53.36%
-0.208
|
-0.446 | -0.289 | -8.871 | -0.274 |
| Income/Loss From Continuing Operations After Tax |
26.95%
-2.391
|
-3.273 | -4.023 | -29.09 | -3.889 |
Net Income/Loss
|
26.95%
-2.391
|
-3.273 | -4.023 | -29.09 | -3.889 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
52.35%
11.51
|
7.5527 | 7.4355 | 0.1149 | 44.61 |
| Diluted Average Shares |
52.35%
11.51
|
7.5527 | 7.4355 | 0.1149 | 44.61 |
| Basic Earnings Per Share |
51.16%
-0.21
|
-0.43 | -0.54 | -0.65 | -0.09 |
| Diluted Earnings Per Share |
51.16%
-0.21
|
-0.43 | -0.54 | -0.65 | -0.09 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):